VF
ONCY

Virtu Financial’s Oncolytics Biotech ONCY Stock Holding History

Virtu Financial’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-77,883
Closed -$68K – 2115
2025
Q4 		$68K Buy
+77,883
New +$84.2K ﹤0.01% 1269
2025
Q1 		– Sell
-98,452
Closed -$90K – 1849
2024
Q4 		$90K Buy
+98,452
New +$102K ﹤0.01% 1044
2024
Q3 		– Sell
-27,442
Closed -$27K – 1733
2024
Q2 		$27K Sell
27,442
-24,447
-47% -$26.6K ﹤0.01% 996
2024
Q1 		$55K Buy
+51,889
New +$58K ﹤0.01% 1008
2023
Q2 		– Sell
-22,918
Closed -$28K – 1878
2023
Q1 		$28K Sell
22,918
-2,035
-8% -$3.19K ﹤0.01% 1178
2022
Q4 		$41K Buy
+24,953
New +$37.9K 0.01% 1116
2021
Q3 		– Sell
-35,425
Closed -$98K – 1827
2021
Q2 		$98K Buy
+35,425
New +$109K 0.01% 1211
2021
Q1 		– Sell
-19,587
Closed -$47K – 1903
2020
Q4 		$47K Buy
+19,587
New +$46.9K 0.01% 1242
2020
Q3 		– Sell
-15,490
Closed -$29K – 1375
2020
Q2 		$29K Buy
+15,490
New +$29.2K ﹤0.01% 1088

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Virtu Financial's ONCY Position: Q1 2026 in Review

Virtu Financial sold out of Oncolytics Biotech (ONCY) in Q1 2026, closing a stake of 77,883 shares — an estimated $68K sold.

Virtu Financial first reported a position in ONCY in Q2 2020 and held it in 9 quarters. The position peaked at $98K in Q2 2021. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Virtu Financial reported no remaining Oncolytics Biotech position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 77,883 Oncolytics Biotech shares in Q1 2026, an estimated $68K.
  • Virtu Financial first reported a position in Oncolytics Biotech in Q2 2020 and held it in 9 quarters.
  • Virtu Financial's Oncolytics Biotech position peaked at $98K in Q2 2021.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.